FC Stock News
Monday, March 19, 2007
AtheroGenics Warns Results Will Disappoint
AtheroGenics Inc. (AGIX) warned of disappointing results for its late stage clinical trial of a heart disease treatment. The stock price plummeted $4.74 to close at $3.09.
posted by FC Market News at
3:23 PM
0 Comments:
Post a Comment
<< Home
About Me
Name:
FC Market News
View my complete profile
Previous Posts
Quanta To Buy InfraSource
SIGA's Smallpox Drug Improves Patient
Servicemaster To Be Acquired
Acadia Pharmaceuticals Reports Positive Trial Results
Gannett Lowers Outlook
Disappointing Trial Results For Adams Respiratory
Fremont General's Credit Line Increased
Accredited Home Sells Loans
Possible Bankruptcy For Bally
Trimeris Downgraded
0 Comments:
Post a Comment
<< Home